08:50~10:30 |
Session 3 “ISRN-Gunma Initiative Advanced Research (GIAR) Joint Symposium” |
|
Modulator: |
Tomoaki Shirao (Gunma Univ) |
|
Chair: |
Jan Schuemann (MGH) |
|
|
Kathryn D. Held (MGH) |
S3-1. |
Using physics simulations to understand and optimize biology in proton therapy (30 min) |
|
|
Harald Paganetti (MGH/Harvard Medical School) |
S3-2. |
TOPAS-nBio: A Monte Carlo track structure toolkit for radiobiology studies (20 min) |
|
|
Aimee L. McNamara (MGH/Harvard Medical School) |
S3-3. |
The direct response of immature developing neurons to X-irradiation or C-ion irradiation (20 min) |
|
|
Anggraeini Puspitasari (Gunma Univ) |
S3-4. |
High-throughput imaging analysis for detecting the effects of irradiation on synaptic status (20 min) |
|
|
Kenji Hanamura (Gunma Univ) |
10:30~10:45 |
Coffee break |
10:45~11:55 |
Session 4 “Neurobiology/Radiation Biology“ |
|
Chair: |
Akihisa Takahashi (Gunma Univ) |
S4-1. |
Lysophosphatidic acid receptor 4 signaling promotes vascular network in brain tumors and improves tumor microenvironment (10 min) |
|
|
Daisuke Eino (Osaka Univ) |
S4-2. |
SOX2 expressing Müller glia is essential for tissue regeneration in irradiated embryonic retina of medaka (Oryzias latipes) (10 min) |
|
|
Takako Yasuda (The Univ of Tokyo) |
S4-3. |
Deep learning–assisted data mining for clonogenic assay-associated literatures (10 min) |
|
|
Shuichiro Komatsu (Gunma Univ) |
S4-4. |
Higher linear energy transfer carbon-ion irradiation induces larger amounts of high mobility group box 1 from human cancer cells (10 min) |
|
|
Masahiro Onishi (Gunma Univ) |
S4-5. |
Drosophila melanogaster as a model organism to study biological effects of proton radiation (10 min) |
|
|
Koichiro Nakajima (Nagoya Proton Therapy Center) |
S4-6. |
Fibronectin on extracellular vesicles from microvascular endothelial cells plays a role for the vesicle uptake into oligodendrocyte precursor cells (10 min) |
|
|
Sho Osawa (Gunma Univ) |
S4-7. |
ncreased lysophosphatidylcholine activates microglia through P2X4 receptor in radiation brain necrosis (10 min) |
|
|
Natsuko Kondo (Kyoto Univ) |
12:00~12:45 |
Luncheon Seminar 2 |
|
Chair: |
Kazuhiko Ogawa (Osaka Univ) |
L-2. |
Radiation therapy for bone metastasis |
|
|
Takashi Uno (Chiba Univ) |
12:50~13:50 |
Session 5 “Translational Research” |
|
Chairs: |
Katsuyuki Shirai (Jichi Medical Univ Saitama Medical Center) |
S5-1. |
Combination therapy using a dopamine receptor D1 agonist and radiation inhibit mammary tumor growth and bone metastatic potentials (10 min) |
|
|
Kazumasa Minami (Osaka Univ) |
S5-2. |
Mutational Profiling of Japanese Cervical Cancer Patients Treated with Radiotherapy (10 min) |
|
|
Yuya Yoshimoto (Gunma Univ) |
S5-3. |
PD-L1 expression in cancer cells is regulated by DNA double-strand break repair pathway (10 min) |
|
|
Hiro Sato (Gunma Univ) |
S5-4. |
Multi-layer omics analysis of castration- and X-ray-resistant prostate cancer cells (10 min) |
|
|
Mototaro Iwanaga (Gunma Univ) |
S5-5. |
m6A RNA modification by METTL3 regulates chemo- and radioresistance in pancreatic cancer cells (10 min) |
|
|
Shotaro Tatekawa (Osaka Univ) |
S5-6. |
Radiogenomics analysis reveals KRAS/SMAD4 mutations as indicator for tumor radioresistance (10 min) |
|
|
Takahiro Oike (Gunma Univ) |
13:50~14:45 |
Session 6 “Recent Developments in Radiation Delivery, Planning, and QA Systems” |
|
Chair: |
Takashi Nakano (Gunma Univ) |
S6-1. |
Recent advances from Varian (9 min) |
|
|
Kenichiro Sugaya (Varian Medical Systems) |
S6-2. |
Worldwide latest information -MR Linac- (9 min) |
|
|
Daisuke Oguri (Elekta) |
S6-3. |
CyberKnife and Radixact —- What are Accuray product line different (9 min) |
|
|
Kazuyuki Kobayashi (Accuray Japan) |
S6-4. |
Hitachi Particle Therapy System and its related technologies (9 min) |
|
|
Masumi Umezawa (Hitachi) |
S6-5. |
Adaptive patient QA -ADAPTIVO- (8 min) |
|
|
Yoshiki Yamaguchi (Chiyoda Technol) |
S6-6. |
Challenge for flameless QA in stereotactic irradiation (8 min) |
|
|
Wataru Takahashi (Toyo Medic) |
14:45~15:00 |
Coffee break |
15:00~16:00 |
Session 7 “Radiation Biology/Oncology” |
|
Chair: |
Kazumasa Minami (Osaka Univ) |
S7-1. |
Inter-assay precision of clonogenic assay for radiosensitivity in human cancer cell lines (10 min) |
|
|
Toshiaki Matsui (Gunma Univ) |
S7-2. |
Prognostic factors for adenocarcinoma of the uterine cervix treated with definitive radiation therapy (10 min) |
|
|
Yuhei Miyasaka (Gunma Univ) |
S7-3. |
Factors promoting DNA end resection at clustered DNA double-strand breaks after carbon-ion particle irradiation (10 min) |
|
|
Yoshihiko Hagiwara (Gunma Univ) |
S7-4. |
Initial experiences with proton therapy using a compact scanning-dedicated machine for patients with prostate cancer (10 min) |
|
|
Taiki Takaoka (Narita Memorial Proton Center) |
S7-5. |
Preclinical study on combined effect of cisplatin with carbon ions or X-rays (10 min) |
|
|
Daijiro Kobayashi (Gunma Univ) |
S7-6. |
Biological effects of prostagrandin E2-EP4 antagonist (AAT-008) : enhancement of immunoresponse to radiotherapy and a potential as a radiosensitizer (10 min) |
|
|
Yoshihiko Manabe (Nagoya City Univ) |